Logotype for Mayne Pharma Group Limited

Mayne Pharma (MYX) investor relations material

Mayne Pharma H2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Mayne Pharma Group Limited
H2 2025 earnings summary28 Aug, 2025

Executive summary

  • Revenue increased 5% year-over-year to $408.1M, driven by Women's Health growth and improved product mix in Dermatology.

  • Underlying EBITDA rose 105% to $47M, reflecting operational leverage and cost control.

  • Operating cash flow from continuing operations surged 460% to $45.4M, despite acquisition and settlement outflows.

  • Cash and marketable securities at year-end were $100.4M, down from $149.3M, after significant earn-out and settlement payments.

  • Shareholders approved a scheme for acquisition by Cosset Pharmaceuticals at $7.4 per share, with court proceedings ongoing.

Financial highlights

  • Gross margin improved to 60.6% from 56.3%, led by Women's Health (80.1%) and Dermatology (53.8%).

  • Revenue increased by $19.7M (5%) year-over-year, led by Women's Health portfolio growth.

  • Underlying EBITDA rose to $47M, up $24.1M from the prior year.

  • Total direct segment contribution increased 24% to $109.7M.

  • Reported net loss after tax narrowed to $(90.1)M from $(168.6)M.

Outlook and guidance

  • Focus on maximizing Women's Health profit potential through sales execution and targeted marketing investments.

  • Dermatology strategy centers on channel differentiation and capital-efficient growth.

  • International segment aims to leverage recent capital investments to expand export revenues and improve profitability.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Mayne Pharma earnings date

Logotype for Mayne Pharma Group Limited
H1 202624 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Mayne Pharma earnings date

Logotype for Mayne Pharma Group Limited
H1 202624 Feb, 2026

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Mayne Pharma Group Limited is an Australian pharmaceutical company engaged in the development, manufacturing, and distribution of branded and generic pharmaceutical products. The company’s portfolio spans various therapeutic areas, including women’s health, dermatology, and pain management, with products available in oral, topical, and injectable forms. Mayne Pharma operates manufacturing facilities in Australia and the United States, and its services include contract development and manufacturing for other pharmaceutical companies. The company is headquartered in Salisbury, South Australia, and its shares are listed on the Australian Securities Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage